AMD — Initiation of Coverage
Published · Dilikoglu Research
- Company / ticker
- Advanced Micro Devices / AMD
- Recommendation
- BUY · High risk
- Price target
- $610 USD · 12–18 months
- Reference price
- $528.75
- Reference date
- 2026-10-16
- Implied upside to target
- 15.4%
Base intrinsic value $607.56 rounded to the nearest $5. The $610 target implies 15.4% upside; unrounded Base upside is 14.9%. Probability-weighted value is $591.16; simulation median $484.44 is below the reference. BUY is a high-risk, Base-led judgment. Dated reference, not a live quote.
Executive summary
Growth has a price. Execution must earn it. AMD’s Instinct and EPYC opportunity must translate into cash returns after working capital, compensation, acquisitions and customer warrants. BUY · High risk with a $610 target, implying 15.4% upside to the October 16 close of $528.75.
Key investment thesis
- Accelerators, server CPUs and software support a substantial growth opportunity.
- Working capital, customer warrants and strategic investment funding determine how much operating growth reaches shareholders.
- The target narrowly exceeds the BUY threshold; long-term competitive returns and downside scenarios remain material.
Target and rating methodology
Rounded Base target above +15% implies BUY, below -15% SELL, otherwise HOLD against the dated reference over 12–18 months. Rounding is material here: unrounded Base upside is 14.9%, versus 15.4% for the $610 target. High risk; simulation frequencies are not calibrated probabilities.
Scenario valuation at publication
Model effective 2026-10-07. Frozen publication snapshot; USD per share. Subsequent model updates appear on the Coverage page.
| Scenario | Probability | Fair value |
|---|---|---|
| Failure | 10% | $12.12 |
| Bear | 25% | $123.00 |
| Base | 45% | $607.56 |
| Bull | 20% | $1429.01 |
Probability-weighted fair value: $591.16. This is separate from the report target.
Key operating assumptions
- FY2027 revenue
- $89.33bn · DR estimate
- FY2030 revenue / non-GAAP operating margin
- $252.45bn / 38% · DR estimates
- Base DCF
- 10% WACC; 3% terminal growth; 30% terminal ROIC · DR estimates
- Dates
- Information review October 18; reference close October 16; valuation balance-sheet date June 27, 2026.
Primary catalysts
- November 3 Q3 earnings release and delivery against guidance.
- Helion partner configurations planned for November; incremental orders and economics require evidence.
Principal risks and thesis breakers
- Accelerator competition, software adoption and growth duration.
- Working capital, conditional customer warrants and undisclosed acquisition terms.
- Monte Carlo median below reference; terminal value represents 70.5% of Base enterprise value.
Repeated shipment delays, guidance misses, pricing concessions or deteriorating cash conversion would require reassessment.
Current evidence review and open items →Report-specific conflicts disclosure
Tugay Dilikoğlu holds no AMD securities, has no other material interest in AMD, and has received no compensation from AMD or any third party for this research.